Two in vitro studies backed by the Spanish supplier report more GLP-1, CCK and short chain fatty acid output. Pharmactive notes no human trials yet.
Recap by typeshit. Full story at Nutrition Insight.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
In rats and minipigs, doses too small to cut weight still reduced heart scarring and stiffness tied to a common heart failure type, researchers report.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Peptide and collagen creams are marketed for firmer skin after GLP-1 weight loss. The piece checks those promises against the available research.
Activist investor Elliott pushed for targets at PepsiCo, and Reuters reports the clock is ticking while GLP-1 drugs weigh on snack demand.
Loading…